Amarin (AMRN) P/B (1999 - 2026)
Amarin (AMRN) P/B from Nov 1, 1999 to Jul 20, 2026. The TTM Amarin (AMRN) P/B is 0.63. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Amarin (AMRN)
| Year | P/B | Change |
|---|---|---|
| 2026 | 0.63 | +0.41% |
| 2025 | 0.63 | +54.01% |
| 2024 | 0.41 | -36.10% |
| 2023 | 0.64 | -22.70% |
| 2022 | 0.83 | -58.51% |
| 2021 | 2.00 | -34.50% |
| 2020 | 3.06 | -75.90% |
| 2019 | 12.69 | -56.40% |
| 2018 | 29.11 | -223.59% |
| 2017 | -23.56 | -143.13% |
| 2016 | 54.62 | -4171.12% |
| 2015 | -1.34 | +38.75% |
| 2014 | -0.97 | -80.75% |
| 2013 | -5.02 | -96.70% |
| 2012 | -152.03 | +806.95% |
| 2011 | -16.76 | +674.36% |
| 2010 | -2.16 | -102.38% |
| 2009 | 90.91 | +156.93% |
| 2008 | 35.38 | +1357.52% |
| 2007 | 2.43 | -88.60% |
| 2006 | 21.29 | +90.00% |
| 2005 | 11.20 | -55.72% |
| 2004 | 25.30 | +75.97% |
| 2003 | 14.38 | -61.40% |
| 2002 | 37.25 | -77.03% |
| 2001 | 162.18 | +215.82% |
| 2000 | 51.35 | +15.79% |
| 1999 | 44.35 | N/A |
Comparison Amarin (AMRN) P/B with competitors
Amarin (AMRN) P/B is 0.63.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| GRFS | Grifols SA | 0.79 | +24.43% |
| SNY | Sanofi | 1.27 | +100.04% |
| BIIB | Biogen Inc | 1.52 | +139.26% |
| PFE | Pfizer Inc | 1.55 | +143.82% |
| OGN | Organon & Company | 3.93 | +518.38% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | +544.37% |
| GSK | GSK Plc | 4.37 | +588.63% |
| BMY | Bristol-Myers Squibb Company | 6.04 | +851.35% |
| AZN | Astrazeneca plc | 6.20 | +876.55% |
| MRK | Merck & Co Inc | 6.68 | +952.16% |
| GILD | Gilead Sciences Inc | 6.94 | +993.11% |
| NVO | Novo Nordisk | 7.07 | +1013.58% |
| NVS | Novartis AG | 7.60 | +1097.06% |
| JNJ | Johnson & Johnson | 7.64 | +1103.36% |
| NSRX | Nasus Pharma Ltd | 12.90 | +1931.86% |
| MDCX | MDCorp | 15.34 | +2316.18% |
| AMGN | AMGEN Inc | 21.17 | +3234.45% |
| SCLX | Scilex Holding Company | 28.85 | +4444.12% |
| LLY | Lilly(Eli) & Company | 32.94 | +5088.33% |
| ABBV | Abbvie Inc | 50.46 | +7847.88% |